Levi Strauss & Co. is a clothing company. The company is headquartered in San Francisco, California.
| Revenue (TTM) | $6.50B |
| Gross Profit (TTM) | $4.01B |
| EBITDA | $944.90M |
| Operating Margin | 12.50% |
| Return on Equity | 25.40% |
| Return on Assets | 7.17% |
| Revenue/Share (TTM) | $16.50 |
| Book Value | $5.74 |
| Price-to-Book | 4.25 |
| Price-to-Sales (TTM) | 1.46 |
| EV/Revenue | 1.676 |
| EV/EBITDA | 11.48 |
| Quarterly Earnings Growth (YoY) | 32.60% |
| Quarterly Revenue Growth (YoY) | 14.10% |
| Shares Outstanding | $98.18M |
| Float | $90.63M |
| % Insiders | 2.08% |
| % Institutions | 95.86% |
Volatility is currently contracting
Levi's NYSE: LEVI turnaround story is one that could be written about in books. The company, an endearing, entrenched, iconic legacy brand, has embraced the modern era, delved deeply into technological advancement, and is now experiencing a virtuous cycle tied to AI.
Levi Strauss' Q2 earnings beat estimates and boosts its FY'26 outlook, yet the stock slides as tariff and foreign exchange pressures remain in focus.
Levi Strauss & Co (NYSE:LEVI) reported second quarter results that topped Wall Street expectations, driven by higher revenue and earnings, while raising its full-year revenue and earnings guidance and increasing its quarterly dividend. The apparel company reported adjusted earnings of $0.28 per diluted share for the quarter ended May 31, ahead of analysts' expectations of $0.24.
Stock futures are slightly higher this morning as investors monitor developments in the Middle East; PepsiCo's results narrowly beat Wall Street estimates as strength in international markets offset sluggish sales in North America; Korean memory chip maker SK Hynix is reportedly seeing heavy demand for its upcoming U.S. stock listing; AstraZeneca shares are sinking after a disappointing heart drug trial; and Levi Strauss shares are falling after the denim apparel maker issued weak guidance. Here's what you need to know today.
Levi Strauss & Co. (LEVI) beat Q2 revenue and EPS expectations, but shares fell on a conservative full-year outlook and tariff headwinds. LEVI posted 7.6% year-over-year revenue growth to $1.56B, with direct-to-consumer sales up 11% and adjusted net income up 24%.
With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Levi Strauss & Co. (LEVI) Q2 2026 Earnings Call Transcript
Levi Strauss & Co. delivered a double beat in Q2, with solid growth across all divisions and an enhanced 2026 outlook. LEVI's revenue grew 6% organically, with strong Americas performance and double-digit growth in Asia; Beyond Yoga expanded 16%. Despite macro headwinds, LEVI expanded margins and projects 7–7.5% net revenue growth and $1.46–$1.52 adj. EPS for 2026.
Jeans maker raises its full-year outlook for the second straight time, but shares fall after hours
The headline numbers for Levi Strauss (LEVI) give insight into how the company performed in the quarter ended May 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
